Tendon reflexes in the legs may be absent (for example, Siguier et al., 1964) example, case 1 of Logothetis et al., 1968) . Cranial nerves may be involved (Logothetis et al., case 2) and the plantar responses extensor (Logothetis et al., case 2) . The protein of the cerebrospinal fluid (CSF) may be normal (Dayan and Lewis, 1966) or raised (Siguier et al., 1964) .
Most of these cases were reported before techniques were available for characterizing cryoglobulins, and it is likely that they are a heterogeneous group, which might explain the varying neurological picture. We report on three patients with neuropathies and cryoglobulinaemia in which the cryoglobulin has been identified and was of the mixed type. Two have not been described before. The third was described by Dayan and Lewis (1966) (Dayan and Lewis 1966) . The CSF was normal. Prednisone was discontinued in 1966. In 1967 she was still troubled by recurrent purpura and leg ulcers but in addition had developed malignant hypertension which was subsequently controlled by chlorothiazide and methyldopa. Another marrow biopsy showed an increase in lymphocytes and plasma cells. It was noted at this time that, although the sheep cell agglutination test was negative, the latex test was strongly positive (1/2,500) and analysis of the cryoglobulin showed that it contained IgM, IgG, and a small amount of IgA. In 1968 she ceased to have purpura but her leg ulcers never healed. After stopping her hypotensive therapy she developed a right-sided hemiplegia from which she recovered as her hypertension responded to treatment. In 1970 she developed gangrene of the right foot. Arteriography showed extensive arteriosclerotic changes in the limb and an above knee amputation was performed.
At her final admission in June 1971, she complained of loss of appetite, diarrhoea, and right hypochondrial pain. Examination revealed generalized weakness, absent knee and ankle jerks, diminished tendon reflexes in the arms but no sensory impairment. She was hypertensive (blood pressure 200/145 mmHg) and had ulcers at the ankle. There was no purpura, lymphadenopathy, or hepatosplenomegaly. Investigation revealed no cause for her symptoms. Shortly after admission she became confused, febrile, and eventually comatose and died. Permission for a postmortem examination was refused.
DISCUSSION
A cryoglobulin may consist of a single component monoclonal immunoglobulin or it may be 'mixed' in that it contains two different immunoglobulins-one of which is an antibody against the other. The antibody component of a mixed cryoglobulin is a 'cold reactive' antibody which acts better in the cold than in the warm and so large precipitable antigen-antibody aggregates form on cooling and dissociate in the warm. The detailed physicochemical processes responsible for cryoprecipitation of single component cryoglobulins are obscure but must again involve the formation of large precipitable aggregates.
Single component cryoglobulins are produced by a clone of cells whose malignant nature is usually obvious as in multiple myeloma or Waldenstrbm's macroglobulinaemia. Occasionally, the clone of cells is apparently benign, as indicated by the fact that there is no relentless increase in the serum level of the abnormal immunoglobulin. Mixed cryoglobulins occur in autoimmune disease and infections. They also occur in lymphomas where the tumour produces an immunoglobulin that happens to b-a coldreactive antiglobulin antibody. Thus, both single and mixed cryoglobulinaemia may be associated with malignancy so that the pathogenesis of a neuropathy in a patient with cryoglobulinaemia could be secondary to the malignancy and unrelated to the presence of the cryoglobulin.
However, cryoglobulins may give rise to vessel damage and, indeed, all three of our patients had cutaneous vasculitis. In one patient there was histological evidence of vasa nervorum vasculitis. Whether vasculitis develops in cryoglobulinaemia depends on several factors. One effect of intravascular precipitation or gelling of a cryoglobulin is an increase in blood viscosity but hyperviscosity is probably relatively unimportant, since vasculitis is not a feature of the hyperviscosity syndrome. Much more important is the ability of certain aggregated immunoglobulins and immune complexes to activate the complement, kinin and clotting systems (Costanzi et al., 1969; Becker, 1971) . Activation of the complement system, for example, leads to the production of a factor chemotactic for polymorphs and release of their proteolytic enzymes. If the aggregated immunoglobulins or immune complexes were coated on to or lodged in a vessel wall acute vasculitis would result.
The pathological properties of mixed cryoglobulins have been demonstrated convincingly. Whitsed and Penny (1971) noted haemorrhagic lesions after intradermal injection of a cryoglobulin in man, while McIntosh et al. (1971) observed glomerulitis after intravenous infusion of cryoglobulins in experimental animals.
The temperature at which cryoprecipitation occurs in vitro varies from one cryoglobulin to another. Rarely, a cryoglobulin may precipitate at 370 C (Sargent et al., 1970) . Most cryoglobulins precipitate only at temperatures well below 370 C, although cryoprecipitation can occur at room temperature and at temperatures found in the superficial skin vessels. At the higher temperatures encountered in deeper vessels, including the vasa nervorum, it is less likely that large cryoglobulin aggregates will be present. Smaller soluble aggregates-still possessing pathogenic properties would, however, be present in these vessels if the antiglobulin antibody shows some activity at the higher temperature, or if immune aggregates have formed in the cooler skin vessels and have not completely dissociated by the time they reach the deeper ones.
Single component cryoglobulins are also capable of activating the complement system (Costanzi et al., 1969) (Gilliatt, 1966) .
It was pointed out above that peripheral nerve damage occurs in only a small proportion of patients with cryoglobulinaemia. The present three cases are from a series of 16 patients with mixed cryoglobulinaemia, a relatively high incidence of 19%. The association may occur more frequently than has been recognized, for in patients with cryoglobulinaemia the neuropathy might be slight enough to be missed unless specifically sought. Conversely, the presence of cryoglobulins in the serum of patients with neuropathy could readily be overlooked (Cream, 1 972b) . The possibility of mixed cryoglobulaemia should therefore be considered when searching for the cause of an undiagnosed neuropathy.
Treatment of cryoglobulinaemia depends on the type of cryoglobulin and the cause. In mixed cryoglobulinaemia, infections and autoimmune disease need to be excluded before antimetabolic drugs are given in an attempt to suppress production of the 'cold reactive' antiglobulin antibody. When a lymphoma is secreting a coldreactive antiglobulin antibody, or a myeloma is producing a single component cryoglobulin, the symptoms may justify the use of antimetabolic drugs and even plasmapheresis.
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